RNS Number : 4418B
World Trade Systems PLC
03 April 2017
WORLD TRADE SYSTEMS PLC ("WTS")
3 April 2017
WTS announces that WTS China, it's wholly-owned health foods subsidiary in China, which develops, produces and sells health enhancing products including functional health drinks, has entered into memorandum of understanding ("MOU") in connection with commercial cooperation agreements with two well established international companies that fit with WTS China's goal and vision. The Board of WTS believes that this will result in the expansion of the business of WTS China by diversifying its product range and extending its market reach.
Co-operation and development of R&D with CHelac Holding GmbH ("CHelac")
WTS China has entered into an MOU with CHelac based in Freiburg, Germany. CHelac owns all of the patents and other intellectual property of the group, including bio-chemical and clinical studies, research and test results, product production rights, and licenses from inventors. It sells the products or ingredients which it has developed to its subsidiaries, CHelac GmbH, which markets the products internationally, and to CHelac AG, which distributes them in Switzerland.
Under the guidance of its research directors, CHelac is engaged in developing active ingredients for the cosmetic and pharmaceutical industries. Its main product thus far is an active complex molecule consisting of natural ingredients known as phytosterols which are extracted from rapeseeds, plus another ingredient known as 4-OPA, which is produced by chemical modification of a molecule extracted from plants. From these two ingredients CHelac has produced an active complex called "CHacoll".
Through extensive testing and research, CHacoll has proven to be effective in stimulating the synthesis of collagen in the skin, thereby principally countering the accumulation of cellulite, preventing sagging and redness of skin, reducing or eliminating itchy skin and enhancing smoothness and elasticity.
WTS China and CHelac are now discussing ways to cooperate and pool their resources in R&D for the purpose of creating new products, which can be sold in their respective markets and internationally.
Product diversification with Fine Japan Co., LTD ("Fine Japan")
WTS China has also entered into an MOU with with Fine Japan which is focused in the health care field in Japan.
Fine Japan is a long-established specialist company in the development of products for beauty enhancing with functional cosmetics, developing special food menus, food for hospitals and the elderly, natural and healthy foods for everyday living, pet foods, food supplements and vitamins.
WTS China hopes to work with Fine Japan in expanding their presence in China by adapting their products and marketing methods to the Chinese market conditions and regulatory environment. WTS China will also look to expand its range of product offerings by working with Japanese partners as OEMs. More detailed announcements will be made in due course.
For more information, please contact the following:
World Trade Systems plc
Mr. Shao Chen, Vice Chairman, firstname.lastname@example.org
Mr. AKM Ismail, Executive Director (Finance), email@example.com
Information on WTS China
Based on its expertise in the Chinese health food industry, with a focused product strategy, a progressive marketing plan, and in depth understanding of consumer trends, WTS China aims to become a comprehensive health food solution provider. WTS China is located in Suzhou, Jiangsu Province, in the central part of eastern China.
WTS China's current health drinks use collagen and other natural ingredients aimed at providing consumers with healthy food supplements containing nutrients which aim to support the body's immune system, improve digestion, lower cholesterol and blood pressure and promote healthier organ functions, smoother and more elastic skin and better complexion. WTS China is active in R&D developing additional products.
WTS China's vision is to become a leading player in distributing many high quality health food products throughout China.
This information is provided by RNS
The company news service from the London Stock Exchange